TB 001
Alternative Names: TB-001Latest Information Update: 25 Apr 2022
At a glance
- Originator Shenzhen Turier Biotech
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Unspecified
Most Recent Events
- 10 Jan 2022 Phase-I clinical trials in Unspecified (In volunteers) in China (SC) (NCT05308940)